Quibim

Quibim stands out for its tissue-agnostic approach to radiomics, offering disease-specific modules (prostate, brain, liver, breast, lung) that plug into clinical workflows via PACS. The cloud platform (QP-Insights) handles imaging data harmonization, linking to EHR and multi-omics, which is crucial for large-scale studies and biopharma partnerships. When to pick this: if you need FDA/CE-marked AI for prostate or brain MRI with quantitative outputs, or if you're a life sciences company seeking imaging biomarkers for drug trials. When to pass: if you require a free tier or self-service pricing—contact sales is the only option. Also, if your workflow is purely research without clinical deployment, the medical device focus may be overkill. Comparison to alternatives: vs. Aidoc or Zebra Medical Vision, Quibim is more specialized in radiomics and quantitative analysis rather than triage or detection. It's less about flagging abnormalities and more about extracting predictive features. Real-world caveats: while the platform promises harmonization across equipment, real-world deployment requires significant data curation and IT integration. The modules like QP-Prostate require specific MRI sequences (PI-RADS compliance), so not all imaging data may be compatible. Additionally, the platform is aimed at enterprise clients, so small clinics might find the implementation heavy.

Quibim is a health technology company that provides AI-powered imaging analysis tools to transform medical imaging data into actionable predictions for improved patient outcomes. Designed for radiologists, oncologists, and life sciences researchers, Quibim's cloud-based platform extracts radiomics and deep features from large-scale imaging registries, enabling the discovery of new biomarkers and supporting clinical decisions. Key features include automated image analysis, imaging data management and harmonization via QP-Insights®, and disease-specific modules like QP-Prostate® for prostate MRI, QP-Brain® for brain volumetry and white matter hyperintensity analysis, QP-Liver® for liver fat and iron quantification, QP-Breast®, and QP-Lung®. The platform integrates with PACS systems, links imaging data with EHR and multi-omics data, and complies with HIPAA, GDPR, and ISO 27001:2022. Quibim partners with biopharma companies to accelerate drug development by identifying trial candidates, monitoring treatment response, and predicting toxicity. Compared to general AI imaging tools, Quibim focuses on tissue-agnostic radiomics and specific clinical workflows with regulatory-grade security.